nodes	percent_of_prediction	percent_of_DWPC	metapath
Captodiame—DRD3—attention deficit hyperactivity disorder	0.876	1	CbGaD
Captodiame—DRD3—Dopamine receptors—DRD5—attention deficit hyperactivity disorder	0.0117	0.097	CbGpPWpGaD
Captodiame—DRD3—Dopamine receptors—DRD1—attention deficit hyperactivity disorder	0.0066	0.0547	CbGpPWpGaD
Captodiame—DRD3—Dopamine receptors—DRD4—attention deficit hyperactivity disorder	0.00621	0.0514	CbGpPWpGaD
Captodiame—DRD3—Dopamine receptors—DRD2—attention deficit hyperactivity disorder	0.00578	0.0479	CbGpPWpGaD
Captodiame—HTR2C—Serotonin receptors—HTR1B—attention deficit hyperactivity disorder	0.00306	0.0253	CbGpPWpGaD
Captodiame—DRD3—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00265	0.0219	CbGpPWpGaD
Captodiame—DRD3—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.00259	0.0214	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00229	0.019	CbGpPWpGaD
Captodiame—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA4—attention deficit hyperactivity disorder	0.00225	0.0187	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.00225	0.0186	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00222	0.0184	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00218	0.018	CbGpPWpGaD
Captodiame—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD4—attention deficit hyperactivity disorder	0.00197	0.0163	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00193	0.016	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00189	0.0156	CbGpPWpGaD
Captodiame—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD2—attention deficit hyperactivity disorder	0.00184	0.0152	CbGpPWpGaD
Captodiame—HTR2C—Serotonin receptors—HTR2A—attention deficit hyperactivity disorder	0.00174	0.0144	CbGpPWpGaD
Captodiame—DRD3—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00157	0.013	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00151	0.0125	CbGpPWpGaD
Captodiame—DRD3—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00146	0.0121	CbGpPWpGaD
Captodiame—DRD3—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00139	0.0115	CbGpPWpGaD
Captodiame—DRD3—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00137	0.0114	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00136	0.0113	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00132	0.0109	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00131	0.0108	CbGpPWpGaD
Captodiame—DRD3—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00128	0.0106	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00127	0.0105	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00123	0.0102	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00123	0.0101	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0012	0.00997	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00119	0.00985	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00117	0.00967	CbGpPWpGaD
Captodiame—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—attention deficit hyperactivity disorder	0.00116	0.00959	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00115	0.00955	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00114	0.00947	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00111	0.00917	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00107	0.00889	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00106	0.0088	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00103	0.00853	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00101	0.00838	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.001	0.00828	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000932	0.00771	CbGpPWpGaD
Captodiame—DRD3—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000895	0.00741	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00082	0.00679	CbGpPWpGaD
Captodiame—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.000811	0.225	CrCbGaD
Captodiame—HTR2C—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000776	0.00642	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000753	0.00623	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000653	0.0054	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00061	0.00504	CbGpPWpGaD
Captodiame—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.000606	0.168	CrCbGaD
Captodiame—Promazine—DRD4—attention deficit hyperactivity disorder	0.000592	0.164	CrCbGaD
Captodiame—DRD3—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00055	0.00455	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00051	0.00422	CbGpPWpGaD
Captodiame—Promazine—DRD1—attention deficit hyperactivity disorder	0.000501	0.139	CrCbGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0005	0.00414	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000497	0.00411	CbGpPWpGaD
Captodiame—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.000465	0.129	CrCbGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000443	0.00366	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000437	0.00362	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000434	0.00359	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000431	0.00356	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00043	0.00356	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000428	0.00355	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000398	0.00329	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000379	0.00314	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000374	0.00309	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000371	0.00307	CbGpPWpGaD
Captodiame—Promazine—DRD2—attention deficit hyperactivity disorder	0.000353	0.098	CrCbGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000347	0.00287	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.000344	0.00285	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000344	0.00285	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000333	0.00276	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000326	0.0027	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000326	0.0027	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000323	0.00268	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000303	0.00251	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000301	0.00249	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000301	0.00249	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000297	0.00246	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000289	0.00239	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000289	0.00239	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000285	0.00236	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000283	0.00234	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000282	0.00233	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000281	0.00232	CbGpPWpGaD
Captodiame—Promazine—HTR2A—attention deficit hyperactivity disorder	0.000273	0.0757	CrCbGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000268	0.00222	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000266	0.0022	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000265	0.00219	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000263	0.00217	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00026	0.00215	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000257	0.00213	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000255	0.00211	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000247	0.00204	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000244	0.00202	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000243	0.00201	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000241	0.002	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000237	0.00196	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000232	0.00192	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00023	0.0019	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00023	0.0019	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000227	0.00188	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000226	0.00187	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000225	0.00186	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000221	0.00183	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000214	0.00177	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000211	0.00175	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000209	0.00173	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000203	0.00168	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000199	0.00165	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000198	0.00164	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000197	0.00163	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000196	0.00162	CbGpPWpGaD
Captodiame—HTR2C—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000194	0.0016	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000188	0.00156	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000184	0.00153	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000184	0.00152	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000183	0.00152	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000175	0.00145	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000173	0.00143	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000173	0.00143	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000173	0.00143	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000171	0.00142	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000171	0.00141	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000167	0.00139	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000163	0.00135	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000161	0.00133	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00016	0.00132	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000159	0.00132	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000154	0.00128	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000152	0.00126	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000151	0.00125	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00015	0.00124	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00015	0.00124	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000148	0.00123	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000148	0.00123	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000145	0.0012	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00014	0.00115	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000131	0.00108	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000128	0.00106	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000128	0.00106	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000118	0.000973	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000116	0.00096	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000113	0.000933	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000112	0.000925	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000112	0.000924	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000111	0.000917	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000104	0.000859	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000102	0.000843	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000101	0.00084	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000101	0.000836	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000101	0.000833	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	9.89e-05	0.000819	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	9.89e-05	0.000818	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	9.77e-05	0.000809	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	9.76e-05	0.000808	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	9.7e-05	0.000803	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	9.69e-05	0.000802	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	9.43e-05	0.00078	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	9.1e-05	0.000753	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	9e-05	0.000745	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	8.98e-05	0.000743	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	8.87e-05	0.000734	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	8.8e-05	0.000728	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	8.75e-05	0.000724	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	8.72e-05	0.000722	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	8.58e-05	0.00071	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	8.57e-05	0.000709	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	8.47e-05	0.000701	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	8.41e-05	0.000696	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.26e-05	0.000684	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	8.18e-05	0.000677	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	7.92e-05	0.000655	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	7.89e-05	0.000653	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	7.78e-05	0.000644	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	7.69e-05	0.000636	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	7.16e-05	0.000593	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.86e-05	0.000567	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.37e-05	0.000527	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.99e-05	0.000496	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.94e-05	0.000492	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.79e-05	0.000479	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.57e-05	0.000461	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.52e-05	0.000457	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.3e-05	0.000439	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.24e-05	0.000433	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.2e-05	0.00043	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.02e-05	0.000415	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.88e-05	0.000404	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.83e-05	0.0004	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.68e-05	0.000387	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.6e-05	0.000381	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.54e-05	0.000376	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.23e-05	0.00035	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.42e-05	0.000283	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.96e-05	0.000245	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.81e-05	0.00015	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.57e-05	0.00013	CbGpPWpGaD
